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Abstract
Traditional methods of isolating membrane proteins involve the use of detergents
that destabilize the membrane environment. Biophysical studies of membrane proteins
are challenged by the requirement of a stable membrane platform. Lipodisq® nanoparticles are novel membrane mimetics that consist of 3:1 styrene-maleic acid copolymer
encircling phospholipids to form discoidal species on the order of 10 nm in diameter.
Bacteriorhodopsin was previously incorporated into Lipodisq® nano-particles from its
native purple membrane without the addition of detergent. In this study, dynamic light
scattering was used to investigate the stability of empty Lipodisq® nano-particles over
time. These data show that Lipodisq® nano-particles are stable for up to 48 hours at both
20 and 30°C. At each temperature, Lipodisq® nano-particles consist of greater than 95%
of the total volume of the sample. Therefore, it is reasonable to investigate the properties
of lipids and membrane proteins in Lipodisq® nano-particles using experimental
techniques that require up to 48 hours.
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Chapter I. Introduction
1.1 Biological Membranes and Membrane Proteins
Biological membranes of cells and organelles delineate environments for different
functional purposes. The major molecular species composing the biological membrane
include phospholipids, sterols, and proteins.

The phospholipid bilayer is a two

dimensional array of amphipathic lipids consisting of a charged, polar phosphate head
group and two nonpolar acyl chains of varying degrees of carbon length and unsaturation.
Common

phospholipid

head

groups

include

phosphatidylcholine,

phosphatidylethanolamine, phosphatidylserine and phosphatidylglycerol.

The acyl

chains lengths are typically in the range of 16 to 22 carbons (1). However, longer and
shorter chain lengths are not uncommon.
In general, lipids undergo a gel to liquid crystalline phase transition at a
characteristic melting temperature. Below the melting temperature, lipid acyl chains are
rigid and packed closely together in the gel phase. As the temperature is increased, lipids
pass a pre-transition into a ripple phase where the acyl chains have greater movement.
Finally, when the temperature reaches the main transition, the acyl chains adopt more
entropically favorable conformations with the greater degrees of freedom. Points of
unsaturation in the carbon backbone of acyl chains introduce rigid angles of rotation that
ultimately increases the disorder of the bilayer(1).
Biological membranes contain integral membrane proteins and surrounding
peripheral proteins. Integral membrane proteins traverse the phospholipid bilayer to
interact with lipid acyl chains, while peripherally associated proteins face one side of the
phospholipid bilayer to interact with lipid head groups and the aqueous environment.
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Important interactions within the lipid bilayer occur between the transmembrane regions
of the integral membrane protein and lipid acyl chains as well as between the extramembranous portions of the protein and lipid head groups. Integral membrane proteins
belong to multiple functional classes such as receptors, transporters, channels, and
enzymes.

1.2 The purple membrane and bacteriorhodopsin
Expressed

in

the

plasma

membrane

of

Halobacterium

salinarum,

bacteriorhodopsin (BR) is an integral membrane protein that consists of seven
transmembrane alpha helices. BR self-associates into trimers in the purple membrane
(PM) as part of a hexagonal two-dimensional array (2). It has a chromophore, all-trans
retinal that has a maximal absorbance at 568 nm and a molar extinction coefficient (ε) of
63,000 M-1cm-1 (3). Upon activation of its photocycle by green light, it generates an
electrochemical gradient by pumping protons across the membrane. This gradient is used
by ATP synthase to synthesize ATP in the cytoplasm (4). The structure of BR served as
a model for other alpha helical membrane proteins prior to the determination of the
crystal structure of rhodopsin, the archetypical G-protein coupled receptor(5).

1.3 Challenges in studying membrane proteins
It is important to study the physical properties of membrane proteins in a welldefined, native-like environment so that experimental observations reflect the underlying
biology. The amphipathic nature and topological considerations of membrane proteins
introduce additional challenges that are not considerations for studying soluble proteins

8
(6). These challenges begin with limitations of obtaining sufficient quantities of protein
for study.

Different techniques require different amounts of protein. Obtaining

membrane proteins in high yield is limited by low levels of membrane protein expressed
in cells and further loss of protein in the purification process (6).

Following this,

membrane proteins must be reconstituted into well-defined model membrane systems that
provide a stable environment for study. Traditionally, membrane proteins have been
effectively isolated by detergents and studied as a solubilized species in the detergent
micelle. Alternatively, they have been incorporated into membrane mimetic platforms
(6). Both detergent and membrane mimetics have associated disadvantages, including
dimensions, limited accessibility of the protein, and decreased protein stability that can
inhibit effective membrane protein studies. Lipodisq® nano-particles are a model
membrane system with an ability to overcome these disadvantages (6, 7).

1.4 Detergents
Detergents are amphipathic molecules that are commonly used to disrupt the
membrane and remove membrane proteins directly from their native environment.
Detergent solubilization progresses along a detergent concentration gradient as follows.
First, detergent monomers partition into the membrane and begin to destabilize it. When
the detergent concentration exceeds the critical micelle concentration the lipid bilayer is
disrupted and fragments. Ultimately, at high detergent concentrations, detergent-lipid
mixed micelles are generated (1). Although some proteins are sufficiently stable in the
micelle to be studied despite removal from the membrane, some are not. For instance,
the initial detergent partitioning into the native bilayer has been shown to destabilize
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rhodopsin even at concentrations below the critical micelle concentration (8). Proteinlipid interactions in a detergent micelle differ vastly from the interactions involved in a
two-dimensional bilayer. Thus, detergents cannot completely substitute for the stability
of a bilayer and are unsuitable as membrane mimetic systems for many studies.

1.5 Membrane model systems
1.5.1 Liposomes
Membrane proteins may be studied in liposomes, lipid vesicles that provide a
reconstituted bilayer of well-defined lipids.

To form liposomes, hydrated lipid

suspensions are mechanically agitated by sonication, successively freeze-dried in liquid
nitrogen or extruded through a membrane filter of a particular size (9). Liposomes can be
unilamellar or multilamellar and typically form heterogeneously with physical
dimensions on the order of a few hundred nanometers in diameter. Only one side of
membrane proteins is accessible for experiments when reconstituted in liposomes (6).
Due to their large size, liposomes are unsuitable for spectrophotometric studies, because
they scatter more light in the UV-Visible range than they transmit. This light scattering
produces an exceptionally high absorbance signal that is outside the linear range, so that
absorbance measurements at 280 nm are no longer directly proportional to protein
concentration. Liposomes are also problematic for spectroscopy studies such as nuclear
magnetic resonance spectroscopy (NMR) and circular dichroism (CD) on membrane
proteins. Large molecules tumble slower with longer rotational correlation times, which
ultimately contribute to spectral line broadening and limit the size of protein that can be
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studied using NMR.

Liposomes are also incompatible for CD because their large

dimensions can scatter light of high enough intensity to interfere with the measurement.

1.5.2 Nanodiscs
Nanodiscs provide a valuable system in which to study membrane proteins. It is a
membrane model system that consists of a planar, discoidal phospholipid bilayer with the
hydrophobic core of the bilayer encircled by two belts of membrane scaffolding protein
(MSP). Derived from lipoproteins, the membrane scaffolding protein length determines
the diameter of the nanodisc, which may range from 10 nm to 12 nm or higher depending
on the protein construct (10, 11). Nanodiscs are formed as follows. Detergent is added
to solubilize membrane proteins from the native membrane.

Detergent solubilized

membrane proteins are mixed with MSP and phospholipids at an experimentally defined
ratio (10-12).

As detergent is removed from the system, the MSPs coil around

phospholipids that surround the membrane protein in an energetically spontaneous
process to form nanodiscs (12). One and two rhodopsins have been reconstituted into
nanodiscs at specific protein to lipid ratios (13). Nanodiscs offer the advantages of
smaller size, a bilayer environment, and access to both sides of the embedded protein.
However, protein stability may be irreversibly affected prior to detergent removal. In
addition, absorbance of the membrane scaffolding protein at 280 nm may interfere with
UV-Vis spectroscopic studies (6).

1.6 Lipodisq® nano-particles
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Amphipathic polymers have been developed to form nanoscale lipid-polymer

assemblies for drug delivery purposes and to serve as membrane mimetics for biophysical
studies of membrane proteins. As was the case for nanodiscs, preparation of membrane
mimetics using many of these amphipathic polymers requires the addition of detergent (6,
7, 14). However, unlike other amphipathic polymers, 3:1 styrene-maleic acid copolymer
has been used for the detergent-free preparation of Lipodisq® nano-particles (15-17).

The 3:1 styrene-maleic acid copolymer can be used at physiologically relevant
temperatures and pH values (6). It is believed to hypercoil around phospholipids such as
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) to form discoidal lipid bilayer (6).
Both BR, with seven transmembrane α-helices, and PagP, a β-barrel, are model
membrane proteins that have been incorporated as single-molecules into Lipodisq® nanoparticles (15). Previous studies have characterized the average size of empty and BRcontaining Lipodisq® nanoparticles to be smaller in diameter than MSP-bound nanodiscs
(15-17). Transmission electron microscopy (TEM) studies have corroborated the results
from dynamic light scattering (DLS) and support the model that Lipodisq® nano-particles
are discoidal structures that range between 5-13 nm in diameter (15, 16).

12
Lipodisq® nano-particles are a developing platform that may be used to study
membrane proteins using various kinds of spectroscopy and single-molecule techniques.
Lipodisq® nano-particles have similar advantages as nanodiscs without the disadvantage
of absorbance at 280 nm of the membrane scaffolding proteins.

Bacteriorhodopsin

incorporated into Lipodisq® nano-particles have been studied with many spectroscopic
techniques including NMR, ESR (DEER), CD and characterized by negative stain TEM
and DLS (15-17).

1.7 Dynamic light scattering
Light scattering is a universal property of molecules that arises from the
polarizability of the electron cloud at the atomic level. While static light scattering detects
the time-averaged intensity of light by observing a large sample volume, dynamic light
scattering detects the individual fluctuations in scattering intensity in a small sample
volume (18). Dynamic light scattering is a noninvasive and highly sensitive biophysical
technique that is capable of detecting a wide range of particle sizes. DLS can provide a
qualitative analysis of the stability of a sample with respect to changes in the light
scattering intensity profile (19, 20).
The technique utilizes a laser beam that provides a monochromatic and coherent
light source to directly measure molecules undergoing Brownian motion (19-21).
Brownian motion corresponds to the random, stochastic collisions between molecules.
The instrument detects the minute time-dependent fluctuations of light scattering
intensity from the sample and generates an autocorrelation function that decays over time
(21).
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The intensity of light scattered at any second in time during the measurement can

be quantified as the photon count rate in kilo counts per second (kcps) (22). The count
rate can provide information about the concentration of the sample. An increase in the
sample concentration corresponds to an increase in count rate, while a decrease in sample
concentration corresponds to a decrease in count rate (22). The time dependent trend of
the count rate for the sample can indicate aggregation if the count rate increases over time
or sedimentation if the count rate decreases over time (19).
The shape of the autocorrelation decay function provides qualitative information
about the sample. Larger molecules scatter more light to the detector than smaller
molecules and produce an autocorrelation function that decays over a longer time. The
width of the autocorrelation function between the time of maximum and minimum
correlation is a graphical indicator of the polydispersity of the sample (22). The
autocorrelation decay can be fit with either a single exponential (known as Cumulants
analysis) or a multiple exponential algorithm (22). A translational diffusion coefficient
that describes a hard sphere with a hydrodynamic Stokes radius is calculated directly
from the fit of the autocorrelation decay (21).
Cumulants analysis of the autocorrelation function calculates the average
hydrodynamic diameter (Z-average diameter) and the polydispersity index (PdI) of the
sample. The polydispersity index is a dimensionless scale between zero and one that
quantifies the degree of polydispersity of a sample (22). Values closer to zero represent
increasingly monodispersed sample composition, while values greater than 0.7 indicates
that the sample may be too polydisperse for meaningful DLS analysis. The Z-average
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diameter is a value that may be used to compare various unimodal intensity distributions
with polydispersity values less than 0.3 (19, 22).
Size distributions can be plotted by assuming that the sample consists of a
continuous distribution of hydrodynamic radii.

A size distribution by intensity is

generated directly from the autocorrelation fit by plotting the relative scattering intensity
of species in the sample population against the size of each species (21). The intensity
distribution is most suited for meaningful analysis when there is a single peak in the
profile (19). Rayleigh scattering theory is appropriate for analysis of spherical particles
that are much smaller in size than the wavelength of the incident light (21). Under the
Rayleigh approximation, 𝐼 ∝ 𝑑 ! , where I is the intensity of the scattered light and d is the
diameter of the particle (21). Non-spherical particles, including discoidal particles, are
analyzed as spherical particles and described by a hydrodynamic diameter equivalent to
the size of a spherical particle with the same translational diffusion coefficient (21).
Under the conditions that there are multiple peaks, a size distribution by volume
provides a more accurate depiction of the sample constituents. In this case, the Rayleigh
light scattering approximation is no longer appropriate since part of the sample consists
of particles sizes on the order of wavelength of the incident light (21). Application of Mie
theory is necessary to generate analytical solutions using the refractive index of the
sample and transforms the intensity distribution into the volume distribution (19-21).

1.8 Study design
This study investigate will the stability of Lipodisq® nano-particles consisting of
only the SMA polymer and phospholipids (empty Lipodisq® nano-particles) and those
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containing phospholipids and BR (BR Lipodisq® nano-particles) for up to two days. The
phospholipid, 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) with no unsaturated
acyl chains (14:0 PC), will be used for all of the following experiments. Lipodisq®
nanoparticles will be measured at 20 and 30°C bordering the lipid phase transition of
DMPC (Tm = 23°C). For the purposes of this study, dynamic light scattering will be used
to follow the intensity distribution of Lipodisq® nano-particles, the smallest species, to
determine if there is loss of intensity over 48 hours of measurement. The migration of
intensity from Lipodisq® nano-particles to larger species in the overall intensity
distribution will be used as a qualitative measure of stability. The stability of these
Lipodisq® nano-particles over time will provide a relative time frame for which
experiments can be conducted on incorporated proteins. Bacteriorhodopsin will be used
as a model protein for this study as it has been used in Lipodisq® nano-particles
previously for comparison (15, 17).

Chapter II. Methods
2.1 Materials
Lipids were purchased from Avanti Polar Lipids, Inc. and provided by Dr. Nathan
Alder (Department of Molecular and Cell Biology, University of Connecticut, Storrs,
CT).

Dr. Anthony Watts (Department of Biochemistry, University of Oxford, UK)

kindly provided the 3:1 styrene-maleic acid (SMA) polymer obtained from Malvern
Cosmeceutics Ltd. Dr. Robert Birge from the (Department of Chemistry, University of
Connecticut, Storrs, CT) kindly provided wild type purple membrane containing
bacteriorhodopsin.
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2.2 Formation of empty Lipodisq® nano-particles
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) in chloroform was dried
down under a nitrogen stream for approximately 20 minutes and put in a vacuum
desiccator overnight to remove remaining traces of organic solvent. The 3:1 styrenemaleic acid (SMA) polymer was prepared to a 2.5% (w/v) solution in 50 mM Tris buffer
(pH 8). DMPC was hydrated to 20 mg/ml with the same buffer and sonicated in a water
bath until opalescent.

DMPC liposomes were made by extruding 17X through 0.4

micron membrane filters. An equivolume amount of 2.5% SMA polymer solution was
added to DMPC liposomes post extrusion and equilibrated on a shaker for one hour. The
solution (final volume: 500 µl) was centrifuged in a Beckman Coulter Optima™
ultracentrifuge (rotor: TLA100) at 20°C, 40,000 RCF, 5 acceleration/5 deacceleration for
40 minutes.

The supernatant was then removed for dynamic light scattering

measurements. Low speed centrifugation at 6238 RCF was carried out in a RevSpin 102
bench top centrifuge in an attempt to purify Lipodisq® nano-particles.

2.3 Bacteriorhodopsin reconstitution into Lipodisq® nano-particles
DMPC liposomes were prepared in 50mM Tris buffer (pH 8) with 300 mM NaCl.
Wild type PM with BR was pelleted a Beckman Coulter Optima™ ultracentrifuge (rotor:
TLA100) at 20°C, 40,000 RCF, 5 acceleration/5 deacceleration for 40 minutes. Purple
membrane was resuspended in DMPC liposomes that were extruded to 400 nm at a 1:5
(wt:wt) ratio of PM:DMPC to reach a final protein to lipid ratio of approximately 1:172
(17). The sample was sonicated in a water bath without heating for approximately 30
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minutes. An equivolume amount of 2.5% SMA polymer solution was added to the
suspension and equilibrated on a shaker for one hour. The solution was centrifuged again
under conditions for pelleting the PM for 40 minutes.

The supernatant was then

removed for dynamic light scattering measurements.

2.4 Dynamic light scattering experiments
Dynamic light scattering experiments were carried out on a Zetasizer Nano S
(Malvern) to determine the intensity distribution of Lipodisq® nano-particles. Sets of ten
experiments with ten seconds of data acquisition per experiment were carried out for each
timed measurement at 15 minutes increments over the course of 48 hours. For the
purposes of generating size distributions, the refractive index of DMPC was set to 1.371
(23, 24). The refractive index of the dispersant was automatically set to 1.331.

Chapter III. Results
3.1 Optimization of Lipodisq® nano-particle formation
DLS determinations were carried out to determine the size distribution of particles
in the Lipodisq® preparation.

Figure 1 is representative of the data obtained from

experiments conducted at 20°C. These data indicate the smallest species exhibit mean
diameters of approximately 6-8 nm and account for 95-100% of the total light scattering
intensity.

The polydispersity indices ranged from 0.10-0.25 for these intensity

distributions, which is consistent with values for a monodispersed sample.
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Empty Lipodisq® nano-particles, the smallest species, have been purified using
size exclusion column chromatography (15, 17). We sought to simplify this procedure by
using differential centrifugation. Lipodisq® nano-particles prepared by centrifugation of
smaller total sample volumes and Lipodisq® nano-particles measured a week after
preparation

both

exhibited

polydisperse

intensity

distributions.

Samples

with

polydisperse intensity distributions were subjected to centrifugation at 6238 RCF and
40,000 RCF to determine whether empty Lipodisq® nano-particles may be purified using
centrifugation (Figure 2a). Lipodisq® nano-particles of approximately 5 nm in diameter
consisted 38.5% of the intensity distribution (Figure 2a) and 99.9% of the volume
distribution (Figure 2b). After the 40 minutes of centrifugation at 40,000 RCF, Lipodisq®
nano-particles of 7 nm in diameter consisted 73.3% of the intensity distribution. One
hundred percent of the volume distribution consisted of 4 nm diameter Lipodisq® nanoparticles. Accordingly, the decrease in photon count rate from 358 kcps to 219 kcps
corresponded to the sample having a higher PdI (0.77) before than after (PdI= 0.38)
centrifugation. Samples with polydisperse intensity distributions were centrifuged 6238
RCF to determine if lower speeds would still produce significant recovery of intensity in
Lipodisq® nano-particles (Figure 2c). Centrifugation at 40,000 RCF for 40 minutes
showed approximately 26% increase in the intensity of Lipodisq® nano-particles, while
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centrifugation at 6238 RCF produced only a slight difference in intensity. The latter
change is probably within the bounds of experimental error.

3.2 Stability of empty Lipodisq® nano-particles
Polydisperse intensity distributions were observed after a week of preparation and
led to further experiments to determine whether Lipodisq® nano-particles remain uniform
in size or undergo significant aggregation into larger species. Since the size distribution
by intensity weights large particles heavier than small particles, aggregates scatter enough
light to disproportionately bias the intensity distribution.

For this reason, the size

distribution by volume was monitored to provide a more accurate depiction of the sample
(Figure 3a-b).

Although the intensity distribution of Lipodisq® nano-particles was

observed in some of the experiments were polydisperse, DLS data indicates that
Lipodisq® nano-particles contribute to greater than 99% of the sample volume (Figure
3c).

20

We were interested in identifying a general time frame in which Lipodisq® nanoparticles remain stable. This would be useful in experimental studies where these nanoparticles are used as a model membrane. The size distribution changes in Lipodisq®
nano-particles were followed at two temperatures, because we were interested in the
stability at temperatures bordering the DMPC phase transition at 23°C. Over the course
of 48 hours, intensity distributions of empty Lipodisq® nano-particles at 20°C varied
negligibly from initial measurements (Figure 4). Since Lipodisq® nano-particles had a
more heterogeneous intensity distribution at 30°C (data not shown), the volume
distribution was used to evaluate the stability (Figure 5). Over the course of 48 hours, the
volume distribution still consists only of Lipodisq® nano-particles. These data indicated
that Lipodisq® nano-particles were stable for at least 48 hours after preparation.
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In Figure 6, the change in percent intensity of Lipodisq® nano-particles was
followed for up to 48 hours at both 20°C and 30°C. Although empty Lipodisq® nanoparticles had different initial intensities for experiments conducted at 20°C and consisted
of more than 70% of the intensity distribution for at least 48 hours. (Figure 6a). Similarly,
empty Lipodisq® nano-particles exhibited almost no change from initial contributions to
the volume distributions in the experiments conducted at 30°C (Figure 6b). Lipodisq®
nano-particles consisted of almost 100% of the volume distribution for the entire 48

22
hours. These data reflect the uniformity of the size distributions for 48 hours both below
and above the melting temperature of DMPC in Figures 4 and 5.

3.3 Optimization of bacteriorhodopsin containing Lipodisq® nano-particles
Wild type bacteriorhodopsin in the purple membrane was not incorporated into
Lipodisq® nano-particles (Figure 7). Based on previous attempts to incorporate BR into
Lipodisq® nano-particles for preliminary TEM studies (Figure 8), we expected to observe
a hypsochromic shift in the absorbance spectra of BR due to incorporation of monomers
instead of trimers (17). The expected shift in retinal absorbance peak from 568 nm to 555
nm is absent in the absorbance spectrum of bacteriorhodopsin-incorporated Lipodisq®
nano-particles.
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Chapter IV. Discussion
In previous studies, dynamic light scattering has been used to measure the
diameter of empty Lipodisq® nano-particles to range between 5-12 nm in diameter (16).
Similarly in this study, empty Lipodisq® nano-particles were the smallest species in the
intensity distribution with Z-average diameters between 6 and 11 nm.

Low

polydispersity index values of 0.10-0.25 and unimodal intensity and volume distributions
were observed for all measurements.

These characteristics are consistent with the

conclusion that empty Lipodisq® nano-particles are uniform in size and are the
predominant species present in the volume distribution of the sample. As a result,
Lipodisq® nano-particles are readily identifiable using DLS measurements and DLS can
be used to confirm the presence of empty Lipodisq® nano-particles in solution.
Gel filtration chromatography has been used to separate BR Lipodisq® nanoparticles from empty ones (15, 17). In general, column chromatography is a fairly highresolution method for purifying and isolating analytes of different sizes from solution. In
this study, we investigated differential centrifugation as a direct, low-resolution method
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for purifying Lipodisq® nano-particles that displayed polydisperse intensity distributions
after formation. Centrifugation of the sample at 40,000 RCF for 40 minutes achieved
approximately a 20% enrichment of intensity in the smallest species, the empty
Lipodisq® nano-particles (Figure 2c). Thus, empty Lipodisq® nano-particles can be
purified by centrifugation with forces of at least 40,000 RCF.

This has practical

implications for the formation of Lipodisq® nano-particles. When Lipodisq® nanoparticles are formed and the sample is polydisperse, centrifugation can be used as a
method of removing massive aggregates. The removal of aggregates effectively
concentrates the Lipodisq® nano-particles into a more uniform population of sizes.
Centrifugation may also be useful to remove aggregates after BR Lipodisq® nanoparticles are purified on a column. This may be investigated further as a lower resolution
method for purifying BR Lipodisq® nano-particles.
After establishing that empty Lipodisq® nano-particles may be purified using
differential centrifugation, we focused our efforts on identifying a valid time frame to
conduct experiments on proteins incorporated into Lipodisq® nano-particles. A 48-hour
time course was carried out to determine the rate of change of the intensity distribution
contributed by Lipodisq® nano-particles below and above the melting temperature of
DMPC (23°C). At 20°C, intensity distributions were stable throughout each 12 hour
period (Figure 4a-d) and the sample consists almost entirely of Lipodisq® nano-particles.
At 30°C, intensity distributions were observed to vary between each 12 hour increment
before settling into an equilibrium state of two peaks after the initial 12 hour period (data
not shown). This may be due to the presence of larger species inducing a nucleation
process that encourages formation of massive particles over time. However, aggregation
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has minimal influence on the overall sample quality since Lipodisq® nano-particles still
consist of the majority of the volume distribution (Figure 5a-d). We concluded that
empty Lipodisq® nano-particles are stable over the course of 48 hours at temperatures
below and above the melting temperature. This determined a time frame of at least 2
days within which empty Lipodisq® nano-particles are stable experimental platforms.
Bacteriorhodopsin was not incorporated for DLS studies using the experimental
procedure described in the methods. We believe that the lack of incorporation is due to
the sonication step in which no heat was applied to the sample. In previous literature, the
purple membrane was sonicated with DMPC liposomes under gentle heating conditions
(17).
Further data must be collected on BR Lipodisq® nano-particles for comparison.
Differential centrifugation will most likely be poorly equipped for separating empty
Lipodisq® nano-particles from BR Lipodisq® nano-particles. Sucrose gradient
centrifugation, which separates analytes based on their relative densities, may be a viable
alternative for separating empty Lipodisq® nano-particles from BR Lipodisq® nanoparticles.
Even without additional data, these experiments with empty nano-particles
indicate that incorporation of bacteriorhodopsin from the purple membrane should not
significantly impact stability since bacteriorhodopsin in the purple membrane alone is
extremely stable. DLS size distributions of bacteriorhodopsin-incorporated Lipodisq®
nano-particles would most likely be consistent with results obtained for empty nanoparticles since the hydrodynamic radius would not be expected to alter significantly with
protein incorporation.
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Lipodisq® nano-particles may also be used to incorporate other membrane
proteins in different lipid environments. Varying lipid and protein type in these Lipodisq®
nano-particles may limit the time frame in which experiments can be conducted. This will
depend on the stability of the type of lipid or protein. Individual proteins may have
properties that limit their stability when incorporated into Lipodisq® nano-particles. In
addition, replacing saturated DMPC with other unsaturated lipids may impose a limit on
the stability of Lipodisq® nano-particles since unsaturated lipids spontaneously oxidize
over time.
In conclusion, studies using Lipodisq® nano-particles can be conducted for at least
48 hours with minimal formation of aggregate species. Samples can be stored at
temperatures up to 30°C with little to no effect on uniformity for at least 48 hours.
Beyond 48 hours, it is advisable to centrifuge at 40,000 RCF for 40 minutes to pellet
massive aggregates and recover a more monodispersed sample of Lipodisq® nanoparticles.
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